𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

✍ Scribed by William F. Stenson; Joshua R. Korzenik


Book ID
110086058
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
72 KB
Volume
8
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Immunogenicity and safety of influenza v
✍ Jennifer C.C. deBruyn; Robert Hilsden; Kevin Fonseca; Margaret L. Russell; Gilaa πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

Background: Protection against vaccine-preventable diseases is important in inflammatory bowel disease (IBD) because of increased susceptibility and severity of infection with immunosuppressive therapy. However, immunosuppressive therapy may affect vaccine response. This study aimed to evaluate immu

Cyclooxygenase-2 (COX-2) polymorphisms a
✍ Vibeke Andersen; Elaine Nimmo; Henrik B. Krarup; Hazel Drummond; Jane Christense πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 243 KB πŸ‘ 1 views

## Background: Inflammatory bowel diseases (ibds) are a result of interactions between luminal pathogens and the intestinal immune response. cyclooxygenase-2 (cox-2) plays a key role in the regulation of the inflammatory response upon stimulation by luminal pathogens via toll-like receptors. ## Me